https://orcid.org/0000-0002-8174-7928
Figures & data
Figure 1 Distribution of statin non-users, statin continuators and statin initiators in the cohort. The group that initiated statin treatment was compared to statin naïve patients.
Figure 2 Prevalence of statin use among patients with ALD cirrhosis with respect to calendar year. (Blue) Overall statin users after diagnosis. (Red) Statin user after first ALD cirrhosis diagnosis, initiated treatment before diagnosis. (Green) Statin user after first ALD cirrhosis diagnosis, initiated treatment after first ALD cirrhosis diagnosis.
Table 1 Characteristics of Users and Non-Users at Time of Diagnosis of ALD Cirrhosis
Figure 3 Prevalence of statin use among patients with ALD cirrhosis with respect to time since cirrhosis diagnosis. This analysis is restricted to patients diagnosed with ALD cirrhosis after 1 January 2010.
Table 2 Predictors of Statin Initiation (N=1556) Among the Patients (N=23,516) Who Were Diagnosed with ALD Cirrhosis and Had Not Previously Used Statins
Table 3 Multivariable Analysis of Predictors of Statin Initiation Stratified by Calendar Year
Table 4 Multivariable Analysis of Predictors of Statin Discontinuation (n=904) Among Patients Who Began Using Statins After They Were Diagnosed with ALD Cirrhosis (n=1556)